Get started
Author

K. Fisher

Observed names: K D Fisher, K Fisher, K. D. Fisher
OpenAlex ID: A5110163812
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus
2004 · N K Green, C W Herbert, et al. · Gene Therapy · 203
Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via α6-integrins
2007 · M Stevenson, A B H Hale, et al. · Cancer Gene Therapy · 67
Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells
2005 · M Stevenson, E Boos, et al. · Gene Therapy · 17
Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA
2006 · R C Carlisle, S S Briggs, et al. · Gene Therapy · 13
A Phase 1 Mechanism of Action Study of Intra-Tumoural (It) or Intravenous (Iv) Administration of Enadenotucirev, an Oncolytic Ad11/Ad3 Chimeric Group B Adenovirus in Colon Cancer Patients Undergoing Resection of Primary Tumour
2014 · V. Boni, F. De La Portilla, et al. · Annals of Oncology · 9
A Phase 1 Study of Enadenotucirev, an Oncolytic Ad11/Ad3 Chimeric Group B Adenovirus, Administered Intravenously - Analysis of Dose Expansion and Repeat Cycle Cohorts in Patients with Metastatic Colorectal Cancer (Mcrc)
2014 · E. Calvo, M. Gil Martín, et al. · Annals of Oncology · 8
Adenovirus Retargeting and Systemic Delivery
2003 · L. W. Seymour, K. D. Fisher, et al. · Springer eBooks · 7
A Phase 1 Trial of the Safety, Tolerability, and Biological Effects of Intravenous Enadenotucirev (EnAd), a Novel Oncolytic Virus, in Combination with Chemoradiotherapy in Locally Advanced Rectal Cancer (CEDAR)
2023 · S.M. O'Cathail, M. Qiao, et al. · International Journal of Radiation Oncology*Biology*Physics · 5
PDF
Gene transfer and cell-based therapies
2002 · K. Fisher, Terry Hermiston, et al. · Current opinion in molecular therapeutics · 4
1238eTiP Phase I/IIa, open-label, dose finding, safety and exploratory trial of THEO-260: A novel oncolytic immunotherapy, by intravenous delivery in patients with high grade serous or endometrioid ovarian cancer
2025 · M. Saggese, P. Roxburgh, et al. · Annals of Oncology · 1
2271P Development of an oncolytic virus for the treatment of high grade serous ovarian cancer and other stromal rich tumours
2023 · M. Bazan Peregrino, S.C. Frost, et al. · Annals of Oncology · 1
PDF
117 “Arming” the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
2014 · B. Champion, P. Kodialbail, et al. · European Journal of Cancer · 1
OA07-02. Adenovirus vectors induce expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 infection
2009 · A Benlahrech, J Harris, et al. · Retrovirology · 1
PDF
P17-21. Using ubiquitin fusion to augment CD8+ T cell immune responses against HIV-1 antigens
2009 · T Papagatsias, T Athanasopoulos, et al. · Retrovirology · 1
PDF
Systems for gene delivery based on combination of viral and non-viral vectors
2000 · Robert Carlisle, K. Fisher, et al. · ORCA Online Research @Cardiff (Cardiff University) · 1
888eP Ascitic proteins as mediators of immunosuppression against epithelial cell adhesion molecule (EpCAM) Bi-specific T cell engager (BiTE) activity in colorectal cancer (CRC)
2025 · S. Wheeler, L.F. Furtado O'Mahony, et al. · Annals of Oncology
Optimizing the tolerability of intravenous oncolytic viral immunotherapy administration: A sub-analysis of tolerability and cytokine data from the EVOLVE study of enadenotucirev (EnAd), an oncolytic adenovirus
2017 · H. McElwaine-Johnn, G. Pover, et al. · Annals of Oncology
A mechanism of action study of intra-tumoral or intravenous dosing of enadenotucirev, an oncolytic adenovirus in patients with colon, lung, bladder and renal carcinoma undergoing resection of primary tumor
2016 · R. Garcia-Carbonero, V. Boni, et al. · Annals of Oncology
PDF
Enadenotucirev (ColoAd1) a replication competent oncolytic adenovirus: Construction of a cloning platform for optimizing oncolytic virus activity and transgene delivery
2014 · Prithvi Kodialbail, Nalini Rasiah, et al. · Human Gene Therapy
ColoAd1 a group B oncolytic adenovirus: pre-clinical assessment of potency, safety and selectivity
2012 · Sam Illingworth, Ying Di, et al. · Human Gene Therapy
Inhibition of Immune-suppressive TGF beta in Tumour Models
2011 · Aliaa A. Alamoudi, R Carlisle, et al. · Human Gene Therapy
Development of a Transgenic Reporter Mouse for Positive-Readout siRNA Pharmacodynamic Analysis
2010 · Mark Stevenson, Douglas Owen, et al. · Human Gene Therapy
Human prostate stem cells support replication of a prostate-targeted, conditionally replicating adenovirus
2009 · A.A. Frazier, Robert Carlisle, et al. · Human Gene Therapy
Establishment of a positive-readout reporter system for siRNA
2008 · W L Liu, K. Fisher, et al. · Human Gene Therapy
Systemic delivery of 'Stealth' virus particles for the treatment of cancer
2007 · K. Fisher, N K Green, et al. · The Journal of Gene Medicine
Works count: 30
Citation count: 339
H-index: 7
I10-index: 4
Year
Topic
Type